153 related articles for article (PubMed ID: 34856211)
1. A natural product, voacamine, sensitizes paclitaxel-resistant human ovarian cancer cells.
Pellegrini E; Multari G; Gallo FR; Vecchiotti D; Zazzeroni F; Condello M; Meschini S
Toxicol Appl Pharmacol; 2022 Jan; 434():115816. PubMed ID: 34856211
[TBL] [Abstract][Full Text] [Related]
2. The plant alkaloid voacamine induces apoptosis-independent autophagic cell death on both sensitive and multidrug resistant human osteosarcoma cells.
Meschini S; Condello M; Calcabrini A; Marra M; Formisano G; Lista P; De Milito A; Federici E; Arancia G
Autophagy; 2008 Nov; 4(8):1020-33. PubMed ID: 18838862
[TBL] [Abstract][Full Text] [Related]
3. Voacamine: Alkaloid with its essential dimeric units to reverse tumor multidrug resistance.
Condello M; Pellegrini E; Multari G; Gallo FR; Meschini S
Toxicol In Vitro; 2020 Jun; 65():104819. PubMed ID: 32135239
[TBL] [Abstract][Full Text] [Related]
4. Voacamine, an alkaloid extracted from Peschiera fuchsiaefolia, inhibits P-glycoprotein action in multidrug-resistant tumor cells.
Meschini S; Marra M; Condello M; Calcabrini A; Federici E; Dupuis ML; Cianfriglia M; Arancia G
Int J Oncol; 2005 Dec; 27(6):1597-603. PubMed ID: 16273216
[TBL] [Abstract][Full Text] [Related]
5. Autophagy-mediated chemosensitizing effect of the plant alkaloid voacamine on multidrug resistant cells.
Meschini S; Condello M; Marra M; Formisano G; Federici E; Arancia G
Toxicol In Vitro; 2007 Mar; 21(2):197-203. PubMed ID: 17070665
[TBL] [Abstract][Full Text] [Related]
6. Voacamine, a bisindolic alkaloid from Peschiera fuchsiaefolia, enhances the cytotoxic effect of doxorubicin on multidrug-resistant tumor cells.
Meschini S; Marra M; Calcabrini A; Federici E; Galeffi C; Arancia G
Int J Oncol; 2003 Dec; 23(6):1505-13. PubMed ID: 14612920
[TBL] [Abstract][Full Text] [Related]
7. Physcion-8-O-β-d-glucoside interferes with the nuclear factor-κB pathway and downregulates P-glycoprotein expression to reduce paclitaxel resistance in ovarian cancer cells.
Li X; He Y; Wei L; Zhang J; Li X; Cui W; Zhang S
J Pharm Pharmacol; 2021 Mar; 73(4):545-552. PubMed ID: 33793827
[TBL] [Abstract][Full Text] [Related]
8. Liposomal paclitaxel induces apoptosis, cell death, inhibition of migration capacity and antitumoral activity in ovarian cancer.
Faria RS; de Lima LI; Bonadio RS; Longo JPF; Roque MC; de Matos Neto JN; Moya SE; de Oliveira MC; Azevedo RB
Biomed Pharmacother; 2021 Oct; 142():112000. PubMed ID: 34426249
[TBL] [Abstract][Full Text] [Related]
9. A novel targeted co-delivery nanosystem for enhanced ovarian cancer treatment via multidrug resistance reversion and mTOR-mediated signaling pathway.
Wang X; Xiong T; Cui M; Li N; Li Q; Zhu L; Duan S; Wang Y; Guo Y
J Nanobiotechnology; 2021 Dec; 19(1):444. PubMed ID: 34949180
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic analysis of taxol-induced multidrug resistance in an ovarian cancer cell line.
Wang NN; Zhao LJ; Wu LN; He MF; Qu JW; Zhao YB; Zhao WZ; Li JS; Wang JH
Asian Pac J Cancer Prev; 2013; 14(9):4983-8. PubMed ID: 24175763
[TBL] [Abstract][Full Text] [Related]
11. Cosilencing of PKM-2 and MDR-1 Sensitizes Multidrug-Resistant Ovarian Cancer Cells to Paclitaxel in a Murine Model of Ovarian Cancer.
Talekar M; Ouyang Q; Goldberg MS; Amiji MM
Mol Cancer Ther; 2015 Jul; 14(7):1521-31. PubMed ID: 25964202
[TBL] [Abstract][Full Text] [Related]
12. A multiple-targets alkaloid nuciferine overcomes paclitaxel-induced drug resistance in vitro and in vivo.
Liu RM; Xu P; Chen Q; Feng SL; Xie Y
Phytomedicine; 2020 Dec; 79():153342. PubMed ID: 32992085
[TBL] [Abstract][Full Text] [Related]
13. Co-delivery of Paclitaxel/Atovaquone/Quercetin to regulate energy metabolism to reverse multidrug resistance in ovarian cancer by PLGA-PEG nanoparticles.
Lu Q; Gao W; Chen Z; Liu Z; Wang J; Zeng L; Hu X; Zheng E; Zhang Q; Song H
Int J Pharm; 2024 Apr; 655():124028. PubMed ID: 38518871
[TBL] [Abstract][Full Text] [Related]
14. Combination of Antimalarial and CNS Drugs with Antineoplastic Agents in MCF-7 Breast and HT-29 Colon Cancer Cells: Biosafety Evaluation and Mechanism of Action.
Duarte D; Nunes M; Ricardo S; Vale N
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291699
[TBL] [Abstract][Full Text] [Related]
15. FTY720 enhances chemosensitivity of colon cancer cells to doxorubicin and etoposide via the modulation of P-glycoprotein and multidrug resistance protein 1.
Xing Y; Wang ZH; Ma DH; Han Y
J Dig Dis; 2014 May; 15(5):246-59. PubMed ID: 24868599
[TBL] [Abstract][Full Text] [Related]
16. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction.
Kebsa W; Lahouel M; Rouibah H; Zihlif M; Ahram M; Abu-Irmaileh B; Mustafa E; Al-Ameer HJ; Al Shhab M
Anticancer Agents Med Chem; 2018; 18(9):1330-1337. PubMed ID: 30088453
[TBL] [Abstract][Full Text] [Related]
17. Voacamine modulates the sensitivity to doxorubicin of resistant osteosarcoma and melanoma cells and does not induce toxicity in normal fibroblasts.
Condello M; Cosentino D; Corinti S; Di Felice G; Multari G; Gallo FR; Arancia G; Meschini S
J Nat Prod; 2014 Apr; 77(4):855-62. PubMed ID: 24720452
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of protein glycosylation reverses the MDR phenotype of cancer cell lines.
Wojtowicz K; Januchowski R; Nowicki M; Zabel M
Biomed Pharmacother; 2015 Aug; 74():49-56. PubMed ID: 26349962
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of JAK2 Reverses Paclitaxel Resistance in Human Ovarian Cancer Cells.
Xu Y; Zhang J; Wu J; Zhong S; Li H
Int J Gynecol Cancer; 2015 Nov; 25(9):1557-64. PubMed ID: 26360705
[TBL] [Abstract][Full Text] [Related]
20. Voacamine is a novel inhibitor of EGFR exerting oncogenic activity against colorectal cancer through the mitochondrial pathway.
Chen Y; Yang J; Zuo Y; Zhang C; Pu Y; Ren Q; Li X; Huang Y; Huang H; Yang H; You O; Xia X; Lu A; Shi S; Deng Y; Lu J
Pharmacol Res; 2022 Oct; 184():106415. PubMed ID: 36029932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]